Clinical Trials in Philadelphia

Showing 12581-12600 of 17,926 trials

Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis

NCT01563068

Calcipotriene is a vitamin D3 analog that has been used as topical therapy in adult subjects with plaque-type psoriasis since 1993. Calcipotriene foam, 0.005%, was approved in 2010 for the treatment of plaque psoriasis in adults aged 18 years and older. The current study is a multicenter study in which adolescent subjects (ages 12 to 16 years, inclusive) or their primary caregivers will apply calcipotriene foam, 0.005%, as a thin layer to treatment areas of the body and scalp, excluding the face, under maximal use conditions, twice a day for 14 days and once on Day 15. The safety, tolerability, pharmacodynamics, and pharmacokinetics of calcipotriene will be evaluated

Psoriasis

Mayne Pharma International Pty Ltd18 participantsStarted Apr 2012

San Diego, California, United States • Ormond Beach, Florida, United States • Tampa, Florida, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Improving Quality of Life for African American Female Adolescents With Lupus

NCT00068874

This study will evaluate a program designed to help African American adolescents with lupus (systemic lupus erythematosus or SLE) cope with the disease.

Lupus

Medical University of South Carolina120 participantsStarted Apr 2004

Philadelphia, Pennsylvania, United States

Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis

Improving Quality of Life for African American Female Adolescents With Lupus

Find Trials by Condition in Philadelphia

Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

Effect of Hip and Core Muscle Strengthening for Patellofemoral Osteoarthritis: A Feasibility Study

A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response

The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study

Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity

A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate

A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes

Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention Experiment

A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Radiosurgery or Open Surgery for Epilepsy Trial

Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

LINX Reflux Management System Clinical Study Protocol